Effect on treatment outcome of coinfection with SEN viruses in patients with hepatitis C

Lancet

Volumn 358, Issue 9297, 2001, Pages 1961-1962

  Rigas, Basil ^a,c   Hasan, Izhar ^a   Rehman, Raja ^a   Donahue, Peter ^b   Wittkowski, Knut M ^c   Lebovics, Edward ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Diasorin SpA   (Italy)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; RIBAVIRIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA VIRUS; DRUG EFFECT; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; MALE; PRIORITY JOURNAL; SEN D VIRUS; SEN H VIRUS; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 0035830276     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06968-9     Document Type: Article

References (5)

1. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family
2. SEN virus infection and its relationship to transfusion-associated hepatitis
3. Reporting sexual risk behavior for HIV: A practical risk index and a method for improving risk indices
4. Antiviral chemotherapy for the treatment of hepatitis B virus infections